Kellner Capital’s Arena Pharmaceuticals ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-13,400
Closed -$1.24M – 35
2021
Q4
$1.24M Buy
+13,400
New +$883K 0.57% 21

Kellner Capital's ARNA Position: Q1 2022 in Review

Kellner Capital sold out of Arena Pharmaceuticals (ARNA) in Q1 2022, closing a stake of 13,400 shares — an estimated $1.24M sold.

Kellner Capital first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $1.24M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Kellner Capital reported no remaining Arena Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Kellner Capital sold 13,400 Arena Pharmaceuticals shares in Q1 2022, an estimated $1.24M.
  • Kellner Capital first reported a position in Arena Pharmaceuticals in Q4 2021 and held it in 1 quarter.
  • Kellner Capital's Arena Pharmaceuticals position peaked at $1.24M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals as of Q1 2022.

Based on Kellner Capital's 13F filing for Q1 2022, filed 12 May 2022.